rs398122413
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PM5PP3_Moderate
The NM_000311.5(PRNP):c.633G>C(p.Glu211Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E211Q) has been classified as Pathogenic.
Frequency
Consequence
NM_000311.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRNP | NM_000311.5 | c.633G>C | p.Glu211Asp | missense_variant | 2/2 | ENST00000379440.9 | NP_000302.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRNP | ENST00000379440.9 | c.633G>C | p.Glu211Asp | missense_variant | 2/2 | 1 | NM_000311.5 | ENSP00000368752 | P1 | |
PRNP | ENST00000424424.2 | c.633G>C | p.Glu211Asp | missense_variant | 2/2 | 1 | ENSP00000411599 | P1 | ||
PRNP | ENST00000430350.2 | c.633G>C | p.Glu211Asp | missense_variant | 2/2 | 1 | ENSP00000399376 | P1 | ||
PRNP | ENST00000457586.2 | c.633G>C | p.Glu211Asp | missense_variant | 2/2 | 1 | ENSP00000415284 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Gerstmann-Straussler-Scheinker syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 15, 2012 | - - |
Huntington disease-like 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Glu211 amino acid residue in PRNP. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10790216, 11568919, 12590162, 22965875). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 88922). This variant is also known as c.633C>G. This missense change has been observed in individuals with clinical features of PRNP-related conditions (PMID: 22965875; Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with aspartic acid at codon 211 of the PRNP protein (p.Glu211Asp). The glutamic acid residue is moderately conserved and there is a small physicochemical difference between glutamic acid and aspartic acid. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at